Reaction

Vascular Dementia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 861 reports · 12 co-occurring drugs

As of the last recalculation, Vascular Dementia appears in 861 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is ASENAPINE MALEATE (PRR 45.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Asenapine Maleate1645.545.5
Donepezil Hydrochloride5437.937.9
Rivastigmine2026.326.3
Ranolazine818.718.7
Memantine814.314.3
Memantine Hydrochloride814.314.3
Tafamidis612.412.4
Vibegron39.19.1
Ranibizumab87.37.3
Romosozumab-Aqqg47.27.2
Methoxy Polyethylene Glycol-Epoetin Beta36.66.6
Pimavanserin Tartrate94.04.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.